tiprankstipranks
RenovoRx Announces Completion of Recent Offering
Company Announcements

RenovoRx Announces Completion of Recent Offering

RenovoRx (RNXT) has released an update to notify the public and investors about a regulation fd disclosure.

Pick the best stocks and maximize your portfolio:

On January 29, 2023, the Company issued a press release regarding the closing of an Offering. The press release is included in the current report but is not considered “filed” under Section 18 of the Exchange Act, nor is it subject to the section’s liabilities. It also will not be included in any filings under the Securities Act or the Exchange Act, unless explicitly referenced in those filings.

For further insights into RNXT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyRenovoRx announces SCRI Oncology partners enrolling patients for trial
TheFlyRenovoRx receives first purchase orders for FDA-cleared RenovoCath
TheFlyRenovoRx announces NHCI is enrolling patients for Phase III TIGeR-PaC trial
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App